gfp,
What about the strategy of trying to get thru until a year from now when the results of the sleep apnea study will be in hand? If those are good, and an sNDA is on the horizon, the stock would greatly appreciate. I understand this would be putting a lot of eggs in one basket. It seems to me that if that study is positive, this company is worth some money. There's 18 million people with sleep apnea, about 1.5 on some form of CPAP. All of those and many more would welcome a pill instead. CPAp market is estimated to be 4 billion a year. I'm not trying to pump and I realize there's a lot of ifs, but really the main one is whether the ongoing study is positive.
News 
Market Data 
Discover 
